NEW YORK Today’s novel H1N1 news scare may very well turn out to be a “boy who cried SARS” scenario, in which all the news hype drives frenzied concern through the American consciousness but never culminates into a sharp rise in demand of products — antivirals, N-95 facemasks, hand sanitizers — potentially leaving suppliers and retailers with more inventory than they know what to do with.